Clinical trial
IMPACT 360 Study for Parkinson's Disease
NCT07443293 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- IMPACT 360 Study for Parkinson's Disease
- Lead sponsor
- University of British Columbia
- Phase
- Phase 2
- Overall status
- Active, not recruiting
- Start date
- October 28, 2024
- Completion date
- December 31, 2027
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
parkinson's disease (pd), rem sleep behavior disorder